Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Coya TherapeuticsCOYA | Open-market buy | 24/11/14 | 24/11/14 | 1,800 sh | $7.19 | $12,942 | +25.7% | |
Coya TherapeuticsCOYA | Open-market buy | 24/11/13 | 24/11/13 | 5,000 sh | $7.36 | $36,800 | +100.0% | |
Fred GrossmanChief Medical Officer | Coya TherapeuticsCOYA | Open-market buy | 24/11/11 | 24/11/12 | 2,710 sh | $7.37 | $19,972.7 | No record |
Coya TherapeuticsCOYA | Open-market buy | 24/11/11 | 24/11/12 | 5,000 sh | $7.34 | $36,700 | No record | |
Ann LeeDirector | Coya TherapeuticsCOYA | Open-market buy | 23/08/22 | 24/03/05 | 1,000 sh | $3.62 | $3,620 | +6.1% |
Dov A. Md GoldsteinDirector | Coya TherapeuticsCOYA | Open-market buy | 23/01/03 | 23/01/04 | 10,000 sh | In footnote | No stated value | No record |
Coya TherapeuticsCOYA | Open-market buy | 23/01/03 | 23/01/04 | 7,000 sh | In footnote | No stated value | No record | |
Adrian HepnerChief Medical Officer | Coya TherapeuticsCOYA | Open-market buy | 23/01/03 | 23/01/04 | 10,000 sh | In footnote | No stated value | No record |
Hideki GarrenDirector | Coya TherapeuticsCOYA | Open-market buy | 23/01/03 | 23/01/04 | 2,000 sh | In footnote | No stated value | No record |
Anabella VillalobosDirector | Coya TherapeuticsCOYA | Open-market buy | 23/01/03 | 23/01/04 | 10,000 sh | In footnote | No stated value | No record |
Coya TherapeuticsCOYA | Open-market buy | 23/01/03 | 23/01/04 | 10,000 sh | In footnote | No stated value | No record | |
Ann LeeDirector | Coya TherapeuticsCOYA | Open-market buy | 23/01/03 | 23/01/04 | 10,000 sh | In footnote | No stated value | No record |